Evidence map›Paper›PMID 31163615›Full record

ArticleMarine drugs2019

Anti-Inflammatory Effects of 5α,8α-Epidioxycholest-6-en-3β-ol, a Steroidal Endoperoxide Isolated from

Renato B Pereira, David M Pereira, Carlos Jiménez, Jaime Rodríguez, Rosa M Nieto, Romeu A Videira, Olga Silva, Paula B Andrade, Patrícia Valentão

Open access · goldAbstract read
In one paragraph

Article in Marine drugs, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.1field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Secondary Metabolites from Gorgonian Corals of the GenusMolecules (Basel, Switzerland) · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Renato B PereiraREQUIMTE/LAQV, Laboratório de Farmacognosia, Departamento de Química, Faculdade de Farmácia, Universidade do Porto, R. Jorge Viterbo Ferreira, nº 228, 4050-313 Porto, Portugal. ren.pereira@gmail.com.ORCID 0000-0001-8500-7364
David M PereiraREQUIMTE/LAQV, Laboratório de Farmacognosia, Departamento de Química, Faculdade de Farmácia, Universidade do Porto, R. Jorge Viterbo Ferreira, nº 228, 4050-313 Porto, Portugal. dpereira@ff.up.pt.ORCID 0000-0003-0384-7592
Carlos JiménezDepartamento de Química, Facultade de Ciencias e Centro de Investigacións Científicas Avanzadas (CICA), Universidade da Coruña, E-15071 A Coruña, Spain. carlos.jimenez@udc.es.ORCID 0000-0003-2628-303X
Jaime RodríguezDepartamento de Química, Facultade de Ciencias e Centro de Investigacións Científicas Avanzadas (CICA), Universidade da Coruña, E-15071 A Coruña, Spain. jaime.rodriguez@udc.es.ORCID 0000-0001-5348-6970
Rosa M NietoDepartamento de Química, Facultade de Ciencias e Centro de Investigacións Científicas Avanzadas (CICA), Universidade da Coruña, E-15071 A Coruña, Spain. rosa.nieto@udc.es.
Romeu A VideiraREQUIMTE/LAQV, Laboratório de Farmacognosia, Departamento de Química, Faculdade de Farmácia, Universidade do Porto, R. Jorge Viterbo Ferreira, nº 228, 4050-313 Porto, Portugal. ravideira@gmail.com.
Olga SilvaResearch Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Av. Professor Gama Pinto, 1649-003 Lisbon, Portugal. osilva@campus.ul.pt.
Paula B AndradeREQUIMTE/LAQV, Laboratório de Farmacognosia, Departamento de Química, Faculdade de Farmácia, Universidade do Porto, R. Jorge Viterbo Ferreira, nº 228, 4050-313 Porto, Portugal. pandrade@ff.up.pt.ORCID 0000-0002-9764-3920
Patrícia ValentãoREQUIMTE/LAQV, Laboratório de Farmacognosia, Departamento de Química, Faculdade de Farmácia, Universidade do Porto, R. Jorge Viterbo Ferreira, nº 228, 4050-313 Porto, Portugal. valentao@ff.up.pt.ORCID 0000-0002-0740-4396
Universidade do Porto · PTUniversidade da Coruña · ESUniversity of Lisbon · PT

Funding

European Regional Development Fund NORTE-01-0145-FEDER-000024Fundação para a Ciência e a Tecnologia PD/BD/113565/2015Fundação para a Ciência e a Tecnologia UID/QUI/50006/2013
6 · The paper itself

Abstract

Sea hares of

Indexed as

Adjuvants, ImmunologicAnimalsAnti-Inflammatory AgentsAplysiaChemical FractionationCholesterol EstersDown-RegulationEnzyme ActivationErgosterolLipopolysaccharidesMacrophagesMagnetic Resonance SpectroscopyMiceNitric Oxide Synthase Type IIRAW 264.7 Cells5alpha,8alpha-epidioxyergosta-6,22-dien-3-beta-olAdjuvants, ImmunologicAnti-Inflammatory AgentsCholesterol EstersErgosterolLipopolysaccharidesNitric Oxide Synthase Type IINos2 protein, mouse5α,8α-epidioxycholest-6-en-3β-olAplysia depilansCOX-1COX-2IL-6iNOSTNF-α

Identifiers

PMID31163615
PMCPMC6628248
OpenAlexW2947944616

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.